NYSE:SYK - Stryker Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $286.43
Forecasted Upside: 3.54 %
Number of Analysts: 22
Breakdown:
1 Sell Ratings
7 Hold Ratings
14 Buy Ratings
0 Strong Buy Ratings

^$276.64 As of 09/24/2021 01:00 AM ET

▲ +0.48 (0.17%)

1 month | 3 months | 12 months

Get New Stryker Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for SYK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SYK

^$286.43

▲ +3.54% Upside Potential

This price target is based on 22 analysts offering 12 month price targets for Stryker in the last 3 months. The average price target is $286.43, with a high forecast of $320.00 and a low forecast of $240.00. The average price target represents a 3.54% upside from the last price of $276.64.

Current Consensus is Buy

The current consensus among 22 polled investment analysts is to buy stock in Stryker. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
13 buy ratings
7 hold ratings
2 sell ratings

Ratings as of

4/4/2020

1 strong buy ratings
16 buy ratings
8 hold ratings
2 sell ratings

Ratings as of

7/3/2020

1 strong buy ratings
15 buy ratings
9 hold ratings
2 sell ratings

Ratings as of

10/1/2020

1 strong buy ratings
15 buy ratings
9 hold ratings
2 sell ratings

Ratings as of

12/30/2020

1 strong buy ratings
14 buy ratings
6 hold ratings
2 sell ratings

Ratings as of

3/30/2021

0 strong buy ratings
13 buy ratings
6 hold ratings
1 sell ratings

Ratings as of

6/28/2021

0 strong buy ratings
14 buy ratings
8 hold ratings
1 sell ratings

Ratings as of

8/27/2021

0 strong buy ratings
14 buy ratings
7 hold ratings
1 sell ratings

Ratings as of

9/26/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
9/14/2021	Raymond James	Initiated Coverage	Market Perform		Medium
7/29/2021	Argus	Boost Price Target	Buy	$280.00 ➝ $320.00	Low
7/28/2021	Truist Securities	Boost Price Target	Hold	$250.00 ➝ $275.00	Medium
7/28/2021	Canaccord Genuity	Boost Price Target	Buy	$285.00 ➝ $290.00	Medium
7/28/2021	Morgan Stanley	Boost Price Target	Overweight	$280.00 ➝ $300.00	Low
7/28/2021	Truist	Boost Price Target	Hold	$250.00 ➝ $275.00	Low
7/28/2021	SVB Leerink	Boost Price Target	Outperform	$290.00 ➝ $300.00	Low
7/28/2021	Credit Suisse Group	Boost Price Target	Outperform	$291.00 ➝ $311.00	Low
7/28/2021	Oppenheimer	Boost Price Target	Market Perform	$273.00 ➝ $288.00	Low
7/28/2021	Northland Securities	Upgrade	Market Perform ➝ Outperform	$248.00 ➝ $310.00	Low
7/28/2021	Needham & Company LLC	Reiterated Rating	Hold		Medium
7/28/2021	Robert W. Baird	Boost Price Target	Outperform	$292.00 ➝ $305.00	Medium
7/28/2021	Citigroup	Boost Price Target	Buy	$303.00 ➝ $310.00	Medium
7/28/2021	Piper Sandler	Boost Price Target	Neutral	$250.00 ➝ $255.00	Medium
7/20/2021	SVB Leerink	Reiterated Rating	Outperform		Medium
6/28/2021	Credit Suisse Group	Reiterated Rating	Buy	$291.00	Low
6/1/2021	Evercore ISI	Upgrade	In-Line ➝ Outperform	$260.00 ➝ $285.00	High
5/24/2021	Barclays	Initiated Coverage	Underweight	$280.00	Low
4/28/2021	Truist Securities	Boost Price Target		$245.00 ➝ $255.00	Medium
4/28/2021	Oppenheimer	Boost Price Target		$240.00 ➝ $273.00	High
4/28/2021	Truist	Boost Price Target		$245.00 ➝ $255.00	High
4/28/2021	Citigroup	Boost Price Target		$264.00 ➝ $303.00	High
4/28/2021	Canaccord Genuity	Boost Price Target	Buy	$275.00 ➝ $285.00	Medium
4/28/2021	Morgan Stanley	Boost Price Target	Overweight	$265.00 ➝ $280.00	Medium
4/28/2021	Wells Fargo & Company	Boost Price Target	Overweight	$265.00 ➝ $300.00	High
4/28/2021	Raymond James	Boost Price Target	Outperform	$255.00 ➝ $290.00	Medium
4/28/2021	Cowen	Boost Price Target	Outperform	$255.00 ➝ $279.00	High
4/28/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$251.00 ➝ $285.00	High
4/28/2021	Robert W. Baird	Boost Price Target	Outperform	$265.00 ➝ $292.00	High
2/24/2021	JPMorgan Chase & Co.	Boost Price Target	Overweight	$245.00 ➝ $265.00	Low
1/28/2021	Credit Suisse Group	Lower Price Target	Outperform ➝ Outperform	$278.00 ➝ $273.00	Low
1/28/2021	Morgan Stanley	Lower Price Target	Overweight	$272.00 ➝ $265.00	High
1/28/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$228.00 ➝ $251.00	Low
1/28/2021	Raymond James	Boost Price Target	Outperform	$240.00 ➝ $255.00	Low
1/28/2021	Needham & Company LLC	Reiterated Rating	Hold		Low
1/6/2021	Truist	Boost Price Target		$210.00 ➝ $245.00	N/A
1/6/2021	Credit Suisse Group	Boost Price Target	Outperform	$253.00 ➝ $278.00	N/A
1/4/2021	Guggenheim	Initiated Coverage	Neutral		N/A
12/31/2020	BTIG Research	Boost Price Target	Buy	$234.00 ➝ $252.00	N/A
12/15/2020	Morgan Stanley	Boost Price Target	Overweight	$225.00 ➝ $272.00	Low
11/12/2020	Robert W. Baird	Boost Price Target	Outperform	$243.00 ➝ $258.00	Low
10/30/2020	Smith Barney Citigroup	Boost Price Target		$232.00 ➝ $240.00	High
10/30/2020	SVB Leerink	Boost Price Target	Outperform	$225.00 ➝ $235.00	High
10/30/2020	Canaccord Genuity	Lower Price Target	Buy	$240.00 ➝ $234.00	High
10/30/2020	Credit Suisse Group	Boost Price Target	Outperform	$243.00 ➝ $253.00	High
10/12/2020	Raymond James	Boost Price Target	Outperform	$220.00 ➝ $240.00	Medium
10/6/2020	Northland Securities	Initiated Coverage	Market Perform	$225.00	Medium
9/28/2020	Wells Fargo & Company	Boost Price Target	Overweight	$222.00 ➝ $232.00	Medium
9/11/2020	Wolfe Research	Initiated Coverage	Market Perform	$230.00	Low
7/31/2020	UBS Group	Boost Price Target	Neutral	$202.00 ➝ $215.00	High
7/31/2020	Morgan Stanley	Boost Price Target	Overweight	$215.00 ➝ $225.00	Low
7/31/2020	SVB Leerink	Boost Price Target	Outperform	$215.00 ➝ $225.00	Medium
7/31/2020	Credit Suisse Group	Boost Price Target	Outperform	$237.00 ➝ $243.00	High
7/31/2020	Needham & Company LLC	Reiterated Rating	Hold		Medium
7/31/2020	Oppenheimer	Reiterated Rating	Hold	$215.00	Medium
7/31/2020	Citigroup	Boost Price Target	Buy	$227.00 ➝ $232.00	Medium
7/15/2020	SVB Leerink	Reiterated Rating	Outperform		Low
5/11/2020	Argus	Lower Price Target	Buy	$240.00 ➝ $230.00	Low
5/1/2020	Citigroup	Boost Price Target	Buy	$200.00 ➝ $215.00	Medium
5/1/2020	Cfra	Lower Price Target	Strong-Buy	$234.00 ➝ $231.00	Low
5/1/2020	Wells Fargo & Company	Boost Price Target	Overweight	$201.00 ➝ $205.00	Medium
5/1/2020	Morgan Stanley	Boost Price Target	Overweight	$210.00 ➝ $215.00	High
5/1/2020	Stifel Nicolaus	Boost Price Target	Buy	$145.00 ➝ $205.00	High
5/1/2020	UBS Group	Lower Price Target	Neutral	$230.00 ➝ $202.00	High
5/1/2020	Oppenheimer	Reiterated Rating	Hold	$200.00	Medium
5/1/2020	Credit Suisse Group	Boost Price Target	Outperform	$229.00 ➝ $237.00	Medium
5/1/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$243.00 ➝ $228.00	High
4/22/2020	Cowen	Lower Price Target	Outperform	$240.00 ➝ $220.00	Low
4/15/2020	JPMorgan Chase & Co.	Lower Price Target	Overweight	$240.00 ➝ $210.00	Medium
4/13/2020	Raymond James	Lower Price Target	Outperform	$240.00 ➝ $205.00	High
4/13/2020	Barclays	Downgrade	Equal Weight ➝ Underweight	$155.00	High
4/1/2020	Wells Fargo & Company	Lower Price Target	Overweight	$243.00 ➝ $201.00	Medium
4/1/2020	The Goldman Sachs Group	Downgrade	Buy ➝ Sell	$248.00 ➝ $150.00	High
3/27/2020	Morgan Stanley	Lower Price Target	Overweight	$250.00 ➝ $210.00	Low
3/27/2020	Citigroup	Lower Price Target	Buy	$235.00 ➝ $200.00	Medium
3/25/2020	Credit Suisse Group	Lower Price Target	Outperform	$247.00 ➝ $162.00	Low
3/24/2020	Stifel Nicolaus	Lower Price Target	Buy	$250.00 ➝ $145.00	High
3/6/2020	Credit Suisse Group	Lower Price Target	Outperform	$255.00 ➝ $247.00	Low
3/4/2020	Citigroup	Initiated Coverage	Buy	$235.00	High
2/12/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$248.00	Low
1/30/2020	BTIG Research	Reiterated Rating	Buy		Medium
1/29/2020	Cantor Fitzgerald	Reiterated Rating	Neutral		Medium
1/29/2020	Stifel Nicolaus	Boost Price Target	Buy	$245.00 ➝ $250.00	Low
1/29/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$239.00 ➝ $243.00	Low
1/29/2020	Robert W. Baird	Boost Price Target	Outperform	$242.00 ➝ $248.00	High
1/29/2020	Morgan Stanley	Boost Price Target	Overweight	$242.00 ➝ $250.00	High
1/7/2020	SunTrust Banks	Initiated Coverage	Hold	$217.00	Low
1/7/2020	Piper Sandler	Downgrade	Overweight ➝ Neutral	$210.00	Low
1/7/2020	Piper Jaffray Companies	Downgrade	Overweight ➝ Neutral	$210.00	Medium
1/3/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$179.00	Low
1/2/2020	Evercore ISI	Upgrade	In-Line ➝ Outperform		Low
12/30/2019	BTIG Research	Boost Price Target	Buy	$228.00 ➝ $236.00	Low
12/17/2019	Morgan Stanley	Boost Price Target	Overweight	$230.00 ➝ $242.00	High
11/5/2019	Barclays	Downgrade	Overweight ➝ Equal Weight	$226.00 ➝ $207.00	High
10/30/2019	Robert W. Baird	Boost Price Target	Outperform	$239.00 ➝ $242.00	Medium
10/30/2019	Canaccord Genuity	Boost Price Target	Buy	$233.00 ➝ $240.00	Medium
10/30/2019	Bank of America	Boost Price Target	Buy	$220.00 ➝ $245.00	High
9/5/2019	BTIG Research	Set Price Target	Buy	$228.00	Medium
9/4/2019	Piper Jaffray Companies	Reiterated Rating	Buy		Low
7/29/2019	BTIG Research	Reiterated Rating	Buy	$228.00	Low
7/26/2019	Raymond James	Set Price Target	Buy	$240.00	Low
7/26/2019	Royal Bank of Canada	Set Price Target	Buy	$220.00	Low
7/26/2019	BMO Capital Markets	Set Price Target	Hold	$216.00	Low
7/26/2019	Barclays	Set Price Target	Buy	$226.00	N/A
7/26/2019	Robert W. Baird	Boost Price Target	Outperform	$206.00 ➝ $239.00	Low
7/26/2019	Credit Suisse Group	Boost Price Target	Outperform	$232.00 ➝ $237.00	Low
7/26/2019	Cantor Fitzgerald	Boost Price Target	Neutral	$190.00 ➝ $230.00	High
7/26/2019	Canaccord Genuity	Boost Price Target	Buy	$195.00 ➝ $233.00	High
7/26/2019	Piper Jaffray Companies	Boost Price Target	Overweight	$205.00 ➝ $240.00	High
7/16/2019	Morgan Stanley	Boost Price Target	Overweight	$218.00 ➝ $230.00	Low
7/15/2019	BTIG Research	Boost Price Target	Buy ➝ Positive	$219.00	Medium
7/11/2019	Credit Suisse Group	Boost Price Target	Outperform	$200.00 ➝ $232.00	Low
7/10/2019	SVB Leerink	Reiterated Rating	Outperform		Low
7/2/2019	Wells Fargo & Company	Boost Price Target	Outperform	$219.00 ➝ $228.00	Low
4/24/2019	Oppenheimer	Boost Price Target	Outperform	$183.00 ➝ $192.00	Low
4/24/2019	Robert W. Baird	Boost Price Target	Outperform ➝ Outperform	$201.00 ➝ $206.00	Low
4/24/2019	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy ➝ Buy	$181.00 ➝ $208.00	Low
4/24/2019	Canaccord Genuity	Boost Price Target	Buy ➝ Buy	$190.00 ➝ $195.00	Low
4/24/2019	Cantor Fitzgerald	Boost Price Target	Neutral ➝ Neutral	$175.00 ➝ $190.00	Low
4/15/2019	Barclays	Boost Price Target	Overweight ➝ Overweight	$203.00 ➝ $211.00	Low
4/1/2019	Wells Fargo & Company	Boost Price Target	Outperform	$214.00 ➝ $219.00	Low
3/19/2019	JPMorgan Chase & Co.	Boost Price Target	Overweight	$200.00 ➝ $215.00	Medium
3/18/2019	BTIG Research	Boost Price Target	Buy	$211.00	Low
3/11/2019	Royal Bank of Canada	Boost Price Target	Outperform ➝ Outperform	$184.00 ➝ $204.00	Medium
3/8/2019	Barclays	Set Price Target	Buy	$203.00	Low
3/4/2019	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$200.00 ➝ $218.00	Low
3/1/2019	Piper Jaffray Companies	Reiterated Rating	Overweight	$205.00	Medium
2/4/2019	SunTrust Banks	Boost Price Target	Buy ➝ Positive	$205.00	Low
1/31/2019	Credit Suisse Group	Upgrade	Outperform		Medium
1/30/2019	Canaccord Genuity	Boost Price Target	Buy	$185.00 ➝ $190.00	High
1/18/2019	Cantor Fitzgerald	Reiterated Rating	Neutral		Medium
1/2/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy ➝ Buy	$179.00	Medium
1/2/2019	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$212.00 ➝ $197.00	Low
1/2/2019	Citigroup	Lower Price Target	Neutral ➝ Neutral	$174.00 ➝ $169.00	Low
1/2/2019	Evercore ISI	Upgrade	In-Line ➝ Outperform	$156.75	Medium
12/17/2018	Credit Suisse Group	Initiated Coverage	Outperform	$195.00	Low
11/27/2018	UBS Group	Initiated Coverage	Neutral	$180.00 ➝ $180.00	High
11/15/2018	Citigroup	Boost Price Target	Neutral ➝ Neutral	$173.00 ➝ $174.00	Medium
11/9/2018	Oppenheimer	Set Price Target	Hold	$170.00	N/A
11/9/2018	Cowen	Set Price Target	Buy	$195.00	Low
11/9/2018	Needham & Company LLC	Reiterated Rating	Hold		Low
10/26/2018	Oppenheimer	Set Price Target	Hold	$170.00	Medium
10/15/2018	Barclays	Initiated Coverage	Overweight ➝ Overweight	$198.00	High
9/13/2018	JPMorgan Chase & Co.	Boost Price Target	Overweight	$200.00	Medium
9/12/2018	BTIG Research	Reiterated Rating	Buy	$187.00	Low
9/11/2018	Needham & Company LLC	Reiterated Rating	Hold		Low
8/16/2018	BTIG Research	Initiated Coverage	Buy	$187.00	Medium
7/25/2018	Oppenheimer	Set Price Target	Hold	$170.00	Medium
7/25/2018	Robert W. Baird	Boost Price Target	Outperform ➝ Outperform	$187.00 ➝ $192.00	Medium
7/25/2018	Canaccord Genuity	Reiterated Rating	Buy	$185.00	Medium
7/25/2018	Citigroup	Boost Price Target	Neutral ➝ Neutral	$171.00 ➝ $173.00	High
7/25/2018	Cantor Fitzgerald	Boost Price Target	Neutral ➝ Neutral	$170.00 ➝ $175.00	High
7/25/2018	Royal Bank of Canada	Reiterated Rating	Buy	$184.00	High
7/25/2018	Needham & Company LLC	Reiterated Rating	Hold		High
7/12/2018	BMO Capital Markets	Reiterated Rating	Hold	$174.00	Low
6/27/2018	Sanford C. Bernstein	Initiated Coverage	Market Perform	$177.00	Medium
6/13/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$170.00	Low
5/1/2018	Citigroup	Boost Price Target	Neutral ➝ Neutral	$166.00 ➝ $171.00	Low
4/27/2018	Canaccord Genuity	Boost Price Target	Buy ➝ Buy	$176.00 ➝ $185.00	Medium
4/27/2018	BMO Capital Markets	Boost Price Target	Market Perform	$170.00	Medium
4/27/2018	Stifel Nicolaus	Boost Price Target	Buy ➝ Buy	$183.00 ➝ $187.00	Low
4/27/2018	Cantor Fitzgerald	Reiterated Rating	Hold ➝ Neutral		High
4/2/2018	Evercore ISI	Initiated Coverage	In-Line	$165.00	Medium
3/15/2018	Raymond James	Initiated Coverage	Outperform	$183.00	Low
2/27/2018	Citigroup	Upgrade	Sell ➝ Neutral	$165.77 ➝ $166.00	Medium
2/26/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$179.00 ➝ $186.00	High
2/1/2018	Oppenheimer	Reiterated Rating	Hold	$165.00	Low
2/1/2018	Citigroup	Reiterated Rating	Market Perform	$156.00 ➝ $165.00	Low
1/31/2018	Guggenheim	Reiterated Rating	Buy		Low
1/31/2018	Piper Jaffray Companies	Reiterated Rating	Buy	$170.00	Low
1/31/2018	Needham & Company LLC	Reiterated Rating	Hold		Medium
1/31/2018	SVB Leerink	Boost Price Target	Outperform ➝ Outperform	$177.00 ➝ $184.00	Low
1/30/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$163.00	Medium
1/26/2018	SunTrust Banks	Reiterated Rating	Buy ➝ Buy	$161.00 ➝ $179.00	Low
1/17/2018	Needham & Company LLC	Reiterated Rating	Hold		Low
1/9/2018	Royal Bank of Canada	Reiterated Rating	Buy	$175.00	Low
1/9/2018	Piper Jaffray Companies	Boost Price Target	Overweight ➝ Overweight	$156.00 ➝ $166.00	Low
1/5/2018	Cantor Fitzgerald	Reiterated Rating	Neutral ➝ Neutral	$163.00	Medium
1/2/2018	Wells Fargo & Company	Reiterated Rating	Outperform	$166.00 ➝ $174.00	Medium
1/2/2018	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight		Medium
12/12/2017	BMO Capital Markets	Upgrade	Market Perform	$163.00	Low
12/7/2017	Needham & Company LLC	Reiterated Rating	Hold		Low
11/24/2017	Robert W. Baird	Upgrade	Neutral ➝ Outperform		N/A
11/17/2017	SunTrust Banks	Reiterated Rating	Buy	$161.00	N/A
11/16/2017	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$161.00 ➝ $173.00	N/A
11/3/2017	Needham & Company LLC	Reiterated Rating	Hold		N/A
10/30/2017	Oppenheimer	Set Price Target	Hold	$148.00 ➝ $156.00	N/A
10/29/2017	Cowen	Set Price Target	Buy	$166.00	N/A
10/27/2017	Barclays	Boost Price Target	Underweight	$137.00 ➝ $148.00	N/A
10/27/2017	Canaccord Genuity	Boost Price Target	Buy ➝ Buy	$155.00 ➝ $162.00	N/A
10/27/2017	Stifel Nicolaus	Boost Price Target	Buy	$158.00 ➝ $168.00	N/A
10/27/2017	Wells Fargo & Company	Boost Price Target		$160.00 ➝ $166.00	N/A
10/27/2017	Piper Jaffray Companies	Reiterated Rating	Buy	$156.00	N/A
10/27/2017	Robert W. Baird	Reiterated Rating	Hold	$161.00	N/A
10/6/2017	Cowen	Set Price Target	Buy	$160.00	N/A
10/2/2017	Royal Bank of Canada	Reiterated Rating	Buy	$155.00	Low
10/2/2017	SunTrust Banks	Reiterated Rating	Buy	$161.00	Medium
9/1/2017	Royal Bank of Canada	Reiterated Rating	Buy	$155.00	N/A
8/29/2017	Argus	Reiterated Rating	Buy	$160.00	Low
8/25/2017	Needham & Company LLC	Upgrade	Underperform ➝ Hold		Low
8/24/2017	Piper Jaffray Companies	Reiterated Rating	Overweight	$148.00	Low
8/24/2017	Canaccord Genuity	Reiterated Rating	Buy	$158.00 ➝ $155.00	Low
8/23/2017	Oppenheimer	Reiterated Rating	Hold		Low
7/30/2017	Cowen	Reiterated Rating	Buy	$150.00 ➝ $160.00	Low
7/28/2017	Stifel Nicolaus	Boost Price Target	Buy	$151.00 ➝ $158.00	High
7/28/2017	Oppenheimer	Set Price Target	Hold	$148.00	High
7/28/2017	Royal Bank of Canada	Boost Price Target	Outperform	$140.00 ➝ $155.00	High
7/11/2017	BMO Capital Markets	Reiterated Rating	Hold	$140.00	Low
7/10/2017	Morgan Stanley	Reiterated Rating	Overweight	$155.00 ➝ $160.00	Low
6/30/2017	Jefferies Financial Group	Reiterated Rating	Hold	$132.00	Low
6/29/2017	Cantor Fitzgerald	Initiated Coverage	Neutral ➝ Neutral	$153.00	Low
6/21/2017	Morgan Stanley	Boost Price Target	Overweight	$145.00 ➝ $155.00	Low
6/19/2017	Oppenheimer	Reiterated Rating	Hold		Low
6/9/2017	Citigroup	Boost Price Target	Sell	$114.00 ➝ $125.00	Low
5/16/2017	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$129.00	Medium
4/29/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$135.00 ➝ $148.00	Low
4/27/2017	Barclays	Reiterated Rating	Sell	$133.00	Low
4/26/2017	Cowen	Set Price Target	Outperform	$135.00 ➝ $150.00	Low
4/26/2017	Royal Bank of Canada	Reiterated Rating	Outperform	$135.00 ➝ $140.00	Medium
4/26/2017	Needham & Company LLC	Reiterated Rating	Sell		Medium
4/17/2017	Piper Jaffray Companies	Reiterated Rating	Overweight	$148.00	Low
4/13/2017	Jefferies Financial Group	Reiterated Rating	Hold	$132.00	Low
4/11/2017	BMO Capital Markets	Reiterated Rating	Hold	$125.00	Low
4/8/2017	Oppenheimer	Set Price Target	Hold	$135.00	Low
3/13/2017	Morgan Stanley	Boost Price Target	Overweight	$135.00 ➝ $145.00	Low
3/3/2017	Royal Bank of Canada	Boost Price Target	Outperform	$129.00 ➝ $135.00	N/A
2/27/2017	Canaccord Genuity	Reiterated Rating	Buy	$137.00	N/A
1/28/2017	Wells Fargo & Company	Reiterated Rating	Outperform	$134.50	N/A
1/25/2017	Oppenheimer	Set Price Target	Hold	$122.00	N/A
1/25/2017	Guggenheim	Set Price Target	Buy	$137.00	N/A
1/25/2017	Jefferies Financial Group	Boost Price Target	Hold	$120.00 ➝ $132.00	N/A
1/25/2017	Barclays	Boost Price Target	Underweight	$120.00 ➝ $122.00	N/A
1/25/2017	Needham & Company LLC	Reiterated Rating	Sell		N/A
1/25/2017	Canaccord Genuity	Boost Price Target	Buy	$127.00 ➝ $137.00	N/A
1/23/2017	Canaccord Genuity	Boost Price Target	Buy	$127.00 ➝ $137.00	N/A
1/6/2017	Needham & Company LLC	Downgrade	Hold ➝ Underperform		N/A
1/6/2017	Royal Bank of Canada	Reiterated Rating	Buy	$129.00	N/A
1/5/2017	Edward Jones	Downgrade	Buy ➝ Hold		N/A
12/21/2016	UBS Group	Upgrade	Neutral ➝ Buy	$121.00 ➝ $133.00	N/A
12/15/2016	UBS Group	Upgrade	Neutral ➝ Buy		N/A
11/13/2016	Needham & Company LLC	Reiterated Rating	Hold		N/A
11/1/2016	BMO Capital Markets	Upgrade	Underperform ➝ Market Perform	$125.00	N/A
10/30/2016	Canaccord Genuity	Set Price Target	Buy	$127.00	N/A
10/30/2016	Oppenheimer	Set Price Target	Hold	$122.00	N/A
10/13/2016	SunTrust Banks	Initiated Coverage	Buy	$140.00	N/A

(Data available from 9/27/2016 forward)

News Sentiment Rating

0.21 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

0 very positive mentions
3 positive mentions
1 negative mentions
0 very negative mentions

Mentions as of

3/1/2021

0 very positive mentions
7 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

3/31/2021

0 very positive mentions
9 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

4/30/2021

0 very positive mentions
6 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

5/30/2021

0 very positive mentions
8 positive mentions
0 negative mentions
0 very negative mentions

Mentions as of

6/29/2021

5 very positive mentions
20 positive mentions
3 negative mentions
1 very negative mentions

Mentions as of

7/29/2021

4 very positive mentions
14 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

8/28/2021

5 very positive mentions
14 positive mentions
5 negative mentions
0 very negative mentions

Mentions as of

9/27/2021

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

Stryker Corp. engages in the provision of medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg, and Neurotechnology & Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The MedSurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling and reprocessed medical devices. The Neurotechnology & Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Today's Range

Now: $276.64

$274.93

$277.56

50 Day Range

MA: $268.51

$248.90

$280.09

52 Week Range

Now: $276.64

$196.09

$281.16

Volume

520,100 shs

Average Volume

1,166,182 shs

Market Capitalization

$104.32 billion

P/E Ratio

50.67

Dividend Yield

0.91%

Beta

0.98

Frequently Asked Questions

What sell-side analysts currently cover shares of Stryker?: The following sell-side analysts have issued reports on Stryker in the last year: Argus, Barclays PLC, BTIG Research, Canaccord Genuity, Citigroup Inc., Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Guggenheim, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Northland Securities, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Robert W. Baird, Smith Barney Citigroup, SVB Leerink LLC, TheStreet, Truist, Truist Securities, and Wells Fargo & Company.
View the latest analyst ratings for SYK.
What is the current price target for Stryker?: 21 Wall Street analysts have set twelve-month price targets for Stryker in the last year. Their average twelve-month price target is $286.43, suggesting a possible upside of 3.5%. Argus has the highest price target set, predicting SYK will reach $320.00 in the next twelve months. Smith Barney Citigroup has the lowest price target set, forecasting a price of $240.00 for Stryker in the next year.
View the latest price targets for SYK.
What is the current consensus analyst rating for Stryker?: Stryker currently has 1 sell rating, 7 hold ratings and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SYK will outperform the market and that investors should add to their positions of Stryker.
View the latest ratings for SYK.
What other companies compete with Stryker?: Other companies that are similar to Stryker include Abbott Laboratories, Medtronic, Intuitive Surgical, Edwards Lifesciences, Becton, Dickinson and, Boston Scientific, IDEXX Laboratories, DexCom, ResMed, Baxter International, STERIS, Insulet, Hologic, Teleflex and Abiomed.
How do I contact Stryker's investor relations team?: Stryker's physical mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company's listed phone number is (269) 385-2600 and its investor relations email address is [email protected] The official website for Stryker is www.strykercorp.com.

NYSE:SYK - Stryker Stock Price Target and Predictions

Analyst Price Target for SYK

Current Consensus is Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.21 (Hold)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Stryker?

What is the current price target for Stryker?

What is the current consensus analyst rating for Stryker?

What other companies compete with Stryker?

How do I contact Stryker's investor relations team?